Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Debate On Glucose Control Continues As NICE-SUGAR Results Come In

This article was originally published in The Gray Sheet

Executive Summary

The NICE-SUGAR trial shows that intensive glucose control led to higher mortality rates than conventional control in adults in intensive care units, but experts are cautioning against changing clinical practice until further analyses are available
Advertisement

Related Content

FDA Holds Up Edwards-DexCom Continuous Glucose Monitor For Hospital Use
FDA Holds Up Edwards-DexCom Continuous Glucose Monitor For Hospital Use
Edwards Lifesciences
Edwards Lifesciences

Topics

Advertisement
UsernamePublicRestriction

Register

MT027308

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel